Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Impaired work ability, Insomnia, Musculoskeletal stiffness, Myalgia
Clinical narrative: All next day similar pain, impossible to work.; 6:30pm entire body felt dull heaviness/pain/fatigue; 6:30pm entire body felt dull heaviness/pain/fatigue; Difficulty sleeping; Approximately  6pm stiffness/pain shifted to fingers/toes; Approximately  6pm stiffness/pain shifted to fingers/toes; Several hours after injection, physically drained feeling; Intense pain at site/in arm; Intense pain at site/in arm; Progressing to all over body incl: joints; Progressing to all over body incl: large muscle groups; Progressing to all over body incl:  inner ears; Progressing to all over body incl: skin; Progressing to all over body incl: penis; Progressing to all over body incl:  scrotum; Progressing to all over body incl: anus; Excruciating light sensitivity/eye pain; Excruciating light sensitivity/eye pain; Excruciating light sensitivity/eye pain; upper back.; This is a spontaneous report from a contactable consumer. A 69-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left armon an unknown date in Mar2021 at 10:00 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included gangrenous appendicitis in May2004, diabetes, hypertension, cholesterol high, hernia repair, anaphylaxis  upto 4-6, chronic kidney disease, fracture face and known allergy to insect venom. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included insulin glargine (BASAGLAR), amlodipine (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), glipizide extended release (MANUFACTURER UNKNOWN), magnesium oxide (MANUFACTURER UNKNOWN), carvedilol extended release (MANUFACTURER UNKNOWN), chlortalidone (CHLORTHALIDONE), famotidine (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN (E.C.), colecalciferol (VIT D3) and epinephrine (EPIPEN); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9269) via an unspecified route of administration in the left arm on 09Feb2021 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. On 02Mar2021 at 13:30, several hours after injection, the patient experienced physically drained feeling, intense pain at site/in arm, progressing to all over body including joints, large muscle groups, inner ears, skin, penis, scrotum, anus; excruciating light sensitivity/eye pain; upper back, approximately at 18:00, the patient felt stiffness/pain shifted to fingers/toes and at 18:30, entire body felt dull heaviness/pain/fatigue and difficult sleeping, all next day similar pain, impossible to work. Therapeutic measures were taken as a result of the events which included treatment with paracetamol (TYLENOL) 500 mg several times and rest. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events several hours after injection, physically drained feeling, intense pain at site/in arm progressing to all over body including:  joints, large muscle groups, inner ears, skin, penis, scrotum, anus, excruciating light sensitivity/eye pain; upper back, approximately 6pm stiffness/pain shifted to fingers/toes, 6:30pm entire body felt dull heaviness/pain/fatigue and difficulty sleeping was resolved on an unknown date in Mar2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.